Form D · Biotechnology
Nielsen BioSciences, Inc.
San Diego, CA · CIK 0001685723
Offering snapshot reported Aug 31, 2021 · SEC filing
- Reported sold
- $8.45M Offering amount: $10M
- Investors reported
- Not reported Form D · investor count
- Minimum accepted
- Not reported Reported outside-investor minimum
- First sale
- Not reported As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Aug 31, 2021 | Initial | $8,449,000 | No comparison | Not reported | SEC filing |
| Sep 28, 2016 | Initial | $3,383,000 | No comparison | 65 | SEC filing |
Offering details
- Securities
- Not reported
- Exemptions
- Not reported
- Duration over one year
- Not reported
- Business combination
- Not reported
- Sales commissions
- Not reported
- Finders' fees
- Not reported
- Form D file number
- 021-411738
Source: Form D, filed Aug 31, 2021. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| David P. Burney | Executive |
| Thomas R Carpenter | Director, Executive |
| Robert E. Esch | Director |
| Nelson Lugo | Executive |
| Bruce F. Mackler | Director |
| Scott Nielsen | Executive |
| Stewart Scott Nielsen | Executive |
| Harry Stewart Nielsen, Jr. | Director |
| Gene J. Ostrow | Director |
| John G. Roby | Director |
| David E. Thomas, Jr. | Director |
| Grover Wrenn | Director, Executive |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
11125 Flintkote Avenue, Suite G
San Diego, CA, 92121
San Diego, CA, 92121